E.N. KOROBOV, A.A. YAROVOY, I.M. GORSHKOV, O.V. GOLUBEVA, S.S. KLEYANKINA

Fyodorov Eye Microsurgery Federal State Institution, 59a Beskudnikovsky Blvd., 127486, Moscow, Russian Fedration

 Contact:

Korobov E.N. ― postgraduate student, e-mail: [email protected]

Yarovoy A.A. ― D. Med. Sc., Head of the Department of Ophthalmo-oncology and Radiology, tel. (499) 488-89-43, e-mail: [email protected]

Gorshkov I.M. ― Cand. Med. Sc., Head of the Department of Vitreoretinal Surgery, tel. (499) 488-89-62, e-mail: [email protected]

Golubeva O.V. ― Cand. Med. Sc., Head of the Department of Ophthalmo-oncology and Radiology, tel. (499) 488-89-56, e-mail: [email protected]

Kleyankina S.S. ― Cand. Med. Sc., ophthalmologist of the Department of Ophthalmo-oncology and Radiology, tel. (499) 488-73-21, e-mail: [email protected]

 The study included 25 patients with choroidal melanoma (CM) who underwent endovitreal removal of tumor from 2011 to 2017. Out of 25 patients, there were 13 (52%) men and 12 (48%) women. The patients were from 31 to 80 y.o. (on average 54.4±12.0 y.o.). Endosection of CM in 23 patients was performed after brachytherapy of Ru-106, in 2 patients after gamma-knife. The mean follow-up was 23 months (range 4 to 71 months, standard deviation 17.4 months). None of the patients experienced tumor recurrences into the choroid, conjunctiva, or orbit. Within the indicated follow-up time, all eyes were preserved, metastases were detected in two patients. Secondary endoresection of large CM allows avoiding enucleation and even maintaining vision.

Key words: uveal melanoma, choroidal melanoma, endoresection, brachytherapy.

References

1. Collaborative Ocular Melanoma Study Group. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report no.28. Arch Ophthalmol, 2006, no. 124, pp. 1684-1693.

2. Gragoudas E.S., Lane A.M., Munzenrider J. et al. Long-term risk of local failure after proton therapy for choroidal/ciliary body melanoma. Trans Am Ophthalmol Soc., 2002, no. 100, pp. 43–9.
3. Damato B., Kacperek A., Errington D. et al. Proton beam radiotherapy of uveal melanoma. Saudi J Ophthalmol, 2013, no. № 27(3), pp. 151–157.
4. Bechrakis N.E., Bornfeld N., Zoller , et al. Iodine 125 plaque brachytherapy versus trans-scleral tumor resection in the treatment of large uveal melanomas. Ophthalmology, 2002, no. 109, pp. 1855-1861.
5. Linnik L.F., Legoshin V.A., Shigina N.A. Experimental substantiation of microsurgical intraocular removal of tumors of the choroid in combination with laser coagulation. Laser methods of treatment and angiographic research in ophthalmology. Sat. Scientific. Tr., 1983, pp. 78-81.
6. Peyman G.A., Barrada A. Retinochoroidectomy ab interno. Ophthalmic Surg, 1984, vol. 15, 9, pp. 749–751.
7. Damato B., Groenewald C., McGalliard J., Wong D. Endoresectionof choroidal  Br J Ophthalmol., 1998, no. 82, pp. 213-218.
8. Yarovoy A.A., Gorshkov I.M., Golubeva O.V. Endovitreal removal of uveal melanoma: five years of experience. Effective pharmacotherapy. Oncology, hematology and radiology. Special edition of «Melanoma», 2016, no. 39, pp. 64-68.
9. Caminal J.M., Mejia K., Masuet-Aumadell C. et al. Endoresection versus iodine-125 plaque brachytherapy for the treatment of choroidal melanoma. Am J Ophthalmology, 2013, no. 156, pp. 334-342.
10. Garcia-Arumi J, Leila M, Zapata MA, Velazquez D, Dinares-Fernandez MC, Tresserra F, Corostegui B. Endoresection technique with/without brachyterapy for management of high posterior choroidal melanoma: extended follow-up results. Retina, 2015, no. 35, pp. 628-637.
11. Karkhaneh R., Chams H., Amoli F.A. et all. Long-term surgical outcome of posterior choroidal melanoma treated by endoresection. Retina, 2007, no. 27, pp. 908-1014.
12. Kertes P., Johnson J.J., Peyman G.A. Internal resection of posterior uveal melanomas. Br J Ophthalmol., 1998, no. 82, pp. 1147-1153.
13. Konstantinidis L., Groenewald C., Couplan S.E., Damato B. Long-term outcome of primary endoresection of choroidal melanoma. Br J Ophthalmol., 2014,no. 98, pp. 82-85.
14. Rice J.C., Stannard C., Cook C., Lecuona K. et al. Brachytherapy and endoresection for choroidal melanoma: a cohort study. Br J Ophthalmol., 2014, no. 98, pp. 86-91.
15. Sussskind D., Durr C., Paulsen et all. Endoresection with adjuvant ruthenium brachytherapy for selected uveal melanoma patients — the Tuebingen experience. Acta Ophthalmol., 2016, no. 3, pp. 1-7.
16. Korobov E.N., Yarovoy A.A., Gorshkov I.M. Primary endoresection of choroidal melanoma: meta-analysis of publications. Modern technologies in ophthalmology. Modern technologies of treatment of vitreoretinal pathology, 2017, no. 1, pp. 142-145.
17. Boyko E.V., Zhogolev K.S., Ivanov P.I. et al. Experience of treating patients with melanoma of the choroid with the help of the radiosurgical device «Gamma-knife». Modern technologies in ophthalmology. Modern technologies of treatment of vitreoretinal pathology, 2016, no.1, pp. 40-43.
18. Chang M.Y., McCannel T.A. Local treatment failure after globe-conserving therapy for choroidal melanoma. Br J Ophthalmol., 2013., no. 97, pp. 804-811.
19. Schonfeld S., Cordini D., Riechardt A.I. et all. Proton beam therapy leads to excellent local control rates in choroidal melanoma in the intermediate fundus zone. Am J Ophthalmology, 2014, no. 158, pp. 1184-1191.
20. Seibel , Riechardt A.I., Heufelder J., et all. Adjuvant ab interno tumor treatment after proton beam irradiation. Am J Ophthalmology, 2017, no. 178, pp. 94-100.
21. Yarovoy A.A., Gorshkov I.M., Korobov E.N. New approaches to endosection of choroidal melanoma. Practical Medicine, 2017, no. 9 (110), pp. 272-275.
22. Egger E., Schalenbourg A., Zografos L. et al. Maximizing local tumor control and survival after proton beam radiotherapy of uveal melanoma. Int J Radiat Oncol Biol Phys., 2001, no. 51(1), pp. 138–147.
23. Bechrakis N.E, Petousis V., Krause L., et al. Surgical treatment modalities in uveal melanomas. Klin Monbl Augenheilkd, 2009, no. 226(11), pp. 921-6.
24. Biewald E., Lautner H., Gök M., et al. Endoresection of large uveal melanomas: clinical results in a consecutive series of 200 cases. Br J Ophthalmol., 2016, no. 101(2), pp. 204-8.
25. Shishkin M.M., Reznikova A.B. Combined endoresection of large choroidal melanomas, analysis of long-term results and complications. Sb. Sci. Tr. Scientific-practical. Conf. On ophthalmic surgery with international participation «East-West», 2012, no. 1, pp. 479-481.
26. Sinyavsky O.A., Troyanovsky R.L., Ivanov P.I. et al. Indications for resection and its features in the combined organ-preserving treatment of uveal melanoma with the use of the Gamma knife. Modern technologies in ophthalmology. Modern technologies of treatment of vitreoretinal pathology, 2016, no.1, pp. 201-204.
27. Cassoux N., Cayette S., Plancher C.et al. Choroidal melanoma: does endoresection prevent neovascular glaucoma in patient treated with proton beam irradiation? Retina, 2013, no. 33(7), pp. 1441-7.